Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Coenzyme Q10 As a Treatment for Fatigue and Depression in Multiple Sclerosis Patients: A Double Blind Randomized Clinical Trial Publisher Pubmed



Sanoobar M1 ; Dehghan P2 ; Khalili M3 ; Azimi A4 ; Seifar F3
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Nutrition and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. School of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran
  3. 3. Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  4. 4. Multiple Sclerosis Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Nutritional Neuroscience Published:2016


Abstract

Objectives: Multiple sclerosis (MS) is the chronic inflammatory and demyelinating disorder of central nervous system which is accompanied with disability and negative life style changes such as fatigue and depression. The aim of this study is to investigate the effect of coenzyme Q10 (CoQ10) supplementation on fatigue and depression in patients with MS. Methods: We performed a randomized, double-blinded, placebo-controlled trial to determine the effect of CoQ10 supplement (500 mg/day) vs. placebo for 12 weeks. Fatigue symptoms were quantified by means of fatigue severity scale (FSS) and the Beck depression inventory (BDI) was used to assess depressive symptoms. Results: A significant decrease of FSS was observed in CoQ10 group during the intervention (P = 0.001) and significant increase of FSS change was observed within placebo group (P = 0.001). Repeated measure analysis of variance showed a significant time-by-treatment interaction for FSS (baseline 41.5 ± 15.6 vs. endpoint 45 ± 13.6; F1,45 = 55.23, P < 0.001, η2 = 0.56) and BDI (baseline 17.8 ± 12.2 vs. endpoint 20.4 ± 11.4; F1,45 = 40.3, P < 0.001, η2 = 0.48), indicating significant decrease of FSS and BDI in CoQ10 group compared to placebo group. Conclusion: Our study suggests that CoQ10 supplementation (500 mg/day) can improve fatigue and depression in patients with multiple sclerosis. © W. S. Maney & Son Ltd 2015.
Related Docs
View other Related Docs
1. Coenzyme Q10 Supplementation Ameliorates Inflammatory Markers in Patients With Multiple Sclerosis: A Double Blind, Placebo, Controlled Randomized Clinical Trial, Nutritional Neuroscience (2015)
2. Effect of Aerobic Exercises on Fatigue in Patients With Multiple Sclerosis: A Systematic Review, Physical Therapy Reviews (2025)
3. Fatigue in Multiple Sclerosis Is a Diagnostic Challenge: A Cross-Sectional Study, Journal of Research in Clinical Medicine (2022)
4. Dietary Intake of Coenzyme Q10 Reduces Oxidative Stress in Patients With Acute Ischemic Stroke: A Double-Blind, Randomized Placebo-Controlled Study, Neurological Research (2025)
5. Inhibition of Protein Disulfide Isomerase Has Neuroprotective Effects in a Mouse Model of Experimental Autoimmune Encephalomyelitis, International Immunopharmacology (2020)
6. Cancer Immunotherapy: Friend or Foe of Mental Health?, Cancer Genetics and Psychotherapy (2017)
7. Increased Serum Brain-Derived Neurotrophic Factor in Multiple Sclerosis Patients on Interferon-B and Its Impact on Functional Abilities, Neurologist (2015)
8. The Immunomodulatory Effects of All-Trans Retinoic Acid and Docosahexaenoic Acid Combination Treatment on the Expression of Il-2, Il-4, T-Bet, and Gata3 Genes in Pbmcs of Multiple Sclerosis Patients, Neurological Research (2023)
Experts (# of related papers)
View all Related Experts
Mohammad Ali Sahraian (4)
Abdolreaza Naser Moghadasi (4)
Other Related Docs
9. Effects of Alpha Lipoic Acid Supplementation on Serum Levels of Oxidative Stress, Inflammatory Markers and Clinical Prognosis Among Acute Ischemic Stroke Patients: A Randomized, Double Blind, Tns Trial, Advanced Pharmaceutical Bulletin (2020)
10. Multiple Sclerosis: Clinical Features, Pathophysiology, Diagnosis, and Management, Neuroinflammation (2018)
11. Coenzyme Q10 Supplementation and Oxidative Stress Parameters: A Systematic Review and Meta-Analysis of Clinical Trials, European Journal of Clinical Pharmacology (2020)
12. Multiple Sclerosis Epidemiology in Middle East and North Africa: A Systematic Review and Meta-Analysis, Neuroepidemiology (2015)
13. Lipoic Acid Function and Its Safety in Multiple Sclerosis, Probiotics# Prebiotics# and Synbiotics: Bioactive Foods in Health Promotion (2016)
14. Increased Expression of Mir-301A in Pbmcs of Patients With Relapsing-Remitting Multiple Sclerosis Is Associated With Reduced Nkrf and Pias3 Expression Levels and Disease Activity, Journal of Neuroimmunology (2018)
15. Combination Treatment of Docosahexaenoic Acid (Dha) and All-Trans-Retinoic Acid (Atra) Inhibit Il-17 and Rorγt Gene Expression in Pbmcs of Patients With Relapsing-Remitting Multiple Sclerosis, Neurological Research (2018)
16. Α-Lipoic Acid, Functional Fatty Acid, As a Novel Therapeutic Alternative for Central Nervous System Diseases: A Review, Nutritional Neuroscience (2019)
17. Coenzyme Q10 Enhances Remyelination and Regulate Inflammation Effects of Cuprizone in Corpus Callosum of Chronic Model of Multiple Sclerosis, Journal of Molecular Histology (2021)
18. Coenzyme Q10 Supplementation Reduces Oxidative Stress and Decreases Antioxidant Enzyme Activity in Children With Autism Spectrum Disorders, Psychiatry Research (2018)
19. Saha Improves Depressive Symptoms, Cognitive Impairment and Oxidative Stress: Rise of a New Antidepressant Class, Neurochemical Research (2021)
20. Impact of Supplementation With Multivitamin-Mineral Specially Formulated to Improve Fatigue and Inflammatory State in Patients With Multiple Sclerosis: A Triple-Blind, Randomized, Placebo-Controlled Trial, Current Journal of Neurology (2020)
21. Psychometric Properties of the Persian Version of the Fatigue Impact Scale (Fis-P) in Patients With Multiple Sclerosis, Iranian Rehabilitation Journal (2015)
22. Recent Updates in Imperative Natural Compounds for Healthy Brain and Nerve Function: A Systematic Review of Implications for Multiple Sclerosis, Current Drug Targets (2017)
23. Anxiety- and Depressive-Like Behaviors Are Associated With Altered Hippocampal Energy and Inflammatory Status in a Mouse Model of Crohn's Disease, Neuroscience (2017)
24. Comparison of Cytokine Expression in Multiple Sclerosis Patients and Healthy Volunteers, Acta Medica Iranica (2018)